NEW YORK (GenomeWeb News) — Accelr8 today said it has extended a
licensing agreement with Schott Nexterion that allows Schott to use its surface-coating chemistry to make and market microarray slides.
Under the new two-year agreement, Schott will have access to a version of Accelr8’s OptiChem product to produce its Slide HS microarraying slides.
The OptiChem technology uses a protein to create an even and stable slide surface, according to Accelr8.
Financial terms of the agreement were not released.
The two companies previously extended a 2004 agreement for another version of OptiChem.